Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Plavix sNDA for STEMI granted priority review

Jan. 19, 2006

Recent patents report new treatments for thrombotic disorders

Jan. 18, 2006

Series D financing at Symphogen

Jan. 18, 2006

Nuvelo and Bayer collaborate on alfimeprase

Jan. 11, 2006

HPW-RX2 shown to inhibit thrombin and thromboxane formation

Jan. 10, 2006

New data support Factor Xa inhibition for thromboprophylaxis

Jan. 5, 2006

LY-517717: A novel prophylactic for VTE following major orthopedic surgery

Jan. 2, 2006

YM-477: new orally active TPO agonist

Jan. 2, 2006

New agents with potential for the treatment of thrombotic disorders reported

Dec. 22, 2005

DZ-697b: antithrombotic activity presented

Dec. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...